Optometrists best placed to screen population

Article

Although almost a third of patients referred by optometrists do not have glaucoma, optometrists are still best placed to screen the UK population for glaucoma, according to Dr Aye and colleagues from Northampton General Hospital, UK.

Although almost a third of patients referred by optometrists do not have glaucoma, optometrists are still best placed to screen the UK population for glaucoma, according to Dr Aye and colleagues from Northampton General Hospital, UK.

A study was conducted to review the glaucoma data provided by optometrists on referral forms. A total of 78 referrals were received over a five-month period. The most common reasons for referral were elevated IOP (59%), optic disc abnormalities (45%), visual field defects (14%) and other abnormalities (12%).

A total of 68% of forms were incomplete, missing vital data. Of the IOP measurements, 38% were within 2 mmHg of IOP obtained with Goldmann tonometry and 34% of pneumatonometry readings differed by more than 5 mmHg with that obtained by applanation tonometry. Twenty-seven percent of patients were found not to have glaucoma and were discharged, while 26% of patients were started on treatment.

According to the investigators, despite varying IOP measurements, optometrists are still best placed to screen the UK population for glaucoma.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.